Clinical Trial

Combination Therapy of Anthracyclines for Children With Nephroblastoma

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated March 27, 2019 (before its estimated December 31, 2020 completion). Its status may not reflect the trial's current state.
Summary
This study aims to estimate the efficacy and side effects of study drugs in children with nephroblastoma who are treated with combination therapy.
Trial Details
NCT Number NCT03892330
Lead Sponsor Shengjing Hospital
Conditions 0.5-14 Year Old Children With Nephroblastoma
Enrollment 120 participants
Start Date 2019-06-01
Primary Completion 2020-12-31 (estimated)
Study Completion 2045-06-30 (estimated)
Updated on ClinicalTrials.gov 2019-03-27